At CSIR-Central Drug Research Institute (CSIR-CDRI), I analysed wild-type and mutant LRRK2 kinase systems using protein structure modelling, molecular docking and virtual screening. I processed approximately 55,700 compounds with AutoDock Vina and shortlisted candidates using docking poses and protein–ligand interaction data.
I analysed 100 ns molecular dynamics simulation datasets using RMSD, RMSF, radius of gyration, SASA and hydrogen-bond metrics to assess structural stability and mutation-selective binding. Comparing wild-type, G2019S and I2020T systems, I identified mutation-selective behaviour through integrated structural and simulation-output analysis.
My research interests include protein structure–function relationships, molecular interactions and computational approaches to biological research. I also gained hands-on exposure to bioinformatics workflows and laboratory techniques including DNA/RNA extraction, PCR and ELISA during my industrial training at Rapture Biotech.

